Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
Year: 2021
Type: review
Abstract: Recent advances in diabetes technology have led to the development of closed-loop insulin delivery systems for the management of type 1 diabetes. Several such systems are now commercially available for children and young people. While all available systems have been shown to improve glycaemic control and quality of life in this population, qualitative data also highlights the challenges in using closed-loop systems, which vary among different pediatric age-groups. Very young children require systems that are able to cope with low insulin doses and significant glycaemic variability due to their high insulin sensitivity and unpredictable eating and exercise patterns. Adolescents' compliance is often related to size and number of devices, usability of the systems, need for calibrations, and their ability to interact with the system. Given the speed of innovations, understanding the capabilities and key similarities and differences of current systems can be challenging for healthcare professionals, caregivers and young people with type 1 diabetes alike. The aim of this review is to summarize the key evidence on currently available closed-loop systems for children and young people with type 1 diabetes, as well as commenting on user experience, where real-world data are available. We present findings on a system-basis, as well as identifying specific challenges in different pediatric age-groups and commenting on how current systems might address these. Finally, we identify areas for future research with regards to closed-loop technology tailored for pediatric use and how these might inform reimbursement and alleviate disease burden.
Source: Frontiers in Pediatrics
Authors: Julia Fuchs, Roman Hovorka
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,950
Funders: Leona M. and Harry B. Helmsley Charitable Trust, Wellcome Trust, National Institute for Health and Care Research, European Commission, Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre, National Institute of Diabetes and Digestive and Kidney Diseases, NIHR Evaluation Trials and Studies Coordinating Centre
Awards: G10500178, G2018687014, G2166940007, Institute of Metabolic Science., G434337789, Institute of Metabolic Science., One year day-and-night home closed loop in young people with type 1 diabetes, G5246447471, G7096667669, Effect of closed loop insulin delivery from onset of diabetes in youth on progression of type 1 diabetes, G8585681489, G8589133502, The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
OpenAlex ID: W3158761041